Sputum Microbiota and the Association With Clinical Parameters in Steady-state, Acute Exacerbation and Convalescence of Bronchiectasis (BISER-2)
Guangzhou Institute of Respiratory Disease
Sponsor: Guangzhou Institute of Respiratory Disease
This NA trial investigates Bronchiectasis and is currently ongoing. Guangzhou Institute of Respiratory Disease leads this study, which shows 8 recorded versions since 2015 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jan 2024 — Jul 2024 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jan 2021 — Jan 2024 [monthly]
Recruiting NA
-
Sep 2019 — Jan 2021 [monthly]
Recruiting NA
Status: Unknown Status → Recruiting
▶ Show 3 earlier versions
-
Sep 2018 — Sep 2019 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jun 2018 — Sep 2018 [monthly]
Recruiting NA
-
Jan 2017 — Jun 2018 [monthly]
Recruiting NA
First recorded
Jan 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Guangzhou Institute of Respiratory Disease
For direct contact, visit the study record on ClinicalTrials.gov .